Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

cannabis

  • Home
  •  
  • cannabis



  • Most Read
  • Latest Comments
  • More than 100 children signed up for Zelda’s medicinal cannabis study
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • More than 100 children signed up for Zelda’s medicinal cannabis study
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • More than 100 children signed up for Zelda’s medicinal cannabis study
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • More than 100 children signed up for Zelda’s medicinal cannabis study
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • More than 100 children signed up for Zelda’s medicinal cannabis study
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • More than 100 children signed up for Zelda’s medicinal cannabis study
    • News

    More than 100 children signed up for Zelda’s medicinal cannabis study

    Australian bio-pharmaceutical company Zelda Therapeutics (ASX: ZLD) has continued advancing its observational study which is revealing data around the use of medicinal cannabis for improved behaviour in autistic children. Being conducted at the Children’s Hospital of Philadelphia, the observational study uses parent-reported data to identify doses and formulations of cannabis that improve behaviour, anxiety, sleep,

    Read More
    Public
  • AgTech producer RotoGro delivers $600k order to cannabis company
    • News

    AgTech producer RotoGro delivers $600k order to cannabis company

    Roto-Gro International Limited (ASX: RGO) has reported the delivery of a $600,000 order of their patented Hydroponic Rotational systems to Canadian cannabis company Oakum Cannabis.  The global produce market is expected to grow from $280 billion in 2017 to $295 billion in 2022. Increasing fruit and vegetable consumption is driven by a growing middle class

    Read More
    Public
  • «
  • ‹
  • 8
  • 9
  • 10

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.